Relationship between SLC12A5 expression and clinicopathological features in 195 colorectal cancer cases
| Variable | Low expression (n=125) | Per cent | High expression (n=70) | Per cent | p Value |
|---|---|---|---|---|---|
| Mean age, years±SD | 56.6±12.6 | 59.3±11.4 | 0.86 | ||
| Gender | 0.13 | ||||
| F | 55 | 70.5 | 23 | 29.5 | |
| M | 70 | 59.8 | 47 | 40.2 | |
| Location | 0.39 | ||||
| Colon | 99 | 62.7 | 59 | 37.3 | |
| Rectal | 26 | 70.3 | 11 | 29.7 | |
| Grade | 0.65 | ||||
| High | 13 | 72.2 | 5 | 27.8 | |
| Moderate | 93 | 62.4 | 56 | 37.6 | |
| Low | 19 | 67.9 | 9 | 32.1 | |
| TNM stage | 0.03 | ||||
| I | 46 | 63.0 | 27 | 37.0 | |
| II | 50 | 74.6 | 17 | 25.4 | |
| III | 25 | 58.1 | 18 | 41.9 | |
| IV | 4 | 33.3 | 8 | 66.7 |
The TNM Staging System is based on the extent of the tumor (T), the extent of spread to the lymph nodes (N), and the presence of metastasis (M).